Skip to main content
. 2018 Jan 26;7(1):e26. doi: 10.2196/resprot.9376

Table 4.

Nyvad’s scores [12] at the baseline and after 1 month of treatment (final) for TiF4, NaF and placebo treatments.

Measures TiF4 NaF Placebo
Baseline Final Baseline Final Baseline Final
Nyvad index, mean±SD 1.0±0.00 1.0±0.00 0.97±0.15 1.03±0.15a 0.99±0.06 1.08±0.24b
Dfc, median (min-max) 0.0 (0.0 to 0.0) 0.0 (–0.7 to 0.0) 0.0 (–1.0 to 0.0)

aOne patient presented two teeth that progressed from score 0 to 1 and 1 patient had one lesion that progressed from score 1 to 3.

bOne patient presented one tooth that progressed from score 0 to 3 and one patient had one lesion that progressed from score 1 to 3.

cDf: degrees of freedom. Df = baseline – final value, where positive values indicate regression and negative values indicate lesions progression. Kruskal-Wallis Test (p=.39).